Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review

INTRODUCTION: Although dual antiplatelet therapy (DAPT) is routinely given to patients after percutaneous coronary intervention (PCI) with stenting, the optimal duration is unknown. Recent evidence indicates there may be benefits in extending the duration beyond 12 months but such decisions may incr...

Full description

Saved in:
Bibliographic Details
Published in:BMJ Open
Main Authors: Elliott, Jesse, Kelly, Shannon E, Bai, Zemin, Liu, Wenfei, Skidmore, Becky, Boucher, Michel, So, Derek Y F, Wells, George A
Format: Artigo
Language:Inglês
Published: BMJ Publishing Group 2017
Subjects:
Cardiovascular Medicine
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5387937/
https://ncbi.nlm.nih.gov/pubmed/28377396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-015421
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items